Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
ILA-H5269 | Human | Human IL-5 R alpha / CD125 Protein, Fc Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
ILA-H5259 | Human | Human IL-5 R alpha / CD125 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
ILA-H52H4 | Human | Human IL-5 R alpha / CD125 Protein, His Tag | ![]() |
![]() ![]() |
Loaded Human IL-5, His Tag (Cat. No. IL5-H52H3) on NTA Biosensor, can bind Human IL-5 R alpha, Fc Tag (Cat. No. ILA-H5259) with an affinity constant of 4.63 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Benralizumab | BIW-8405; KHK-4563; MEDI-563; BIW-8405-IL-5R | Approved | Biowa, Medimmune Llc | Fasenra | Japan | Asthma | Astrazeneca Pharmaceutical Co Ltd | 2017-11-14 | Hypereosinophilic Syndrome; Nasal Polyps; Chronic Urticaria; Bronchiectasis; Eosinophilic Esophagitis; Asthma; Sinusitis; Pemphigoid, Bullous; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
CSL-311 | CSL-311 | Phase 2 Clinical | Csl Ltd | Asthma | Details |
This web search service is supported by Google Inc.